Back
Windtree Therapeutics, Inc. 10K Form
Sell
30
WINT
Windtree Therapeutics, Inc.
Last Price:
$0.06
Seasonality Move:
-3.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | WINT/Windtree Therapeutics, Inc. Quarterly |
| 2023-08-07 | 10Q | WINT/Windtree Therapeutics, Inc. Quarterly |
| 2023-05-15 | 10Q | WINT/Windtree Therapeutics, Inc. Quarterly |
| 2022-11-14 | 10Q | WINT/Windtree Therapeutics, Inc. Quarterly |
| 2022-08-11 | 10Q | WINT/Windtree Therapeutics, Inc. Quarterly |
| 2022-05-05 | 10Q | WINT/Windtree Therapeutics, Inc. Quarterly |
Receive WINT News And Ratings
See the #1 stock for the next 7 days that we like better than WINT
WINT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.35 |
| Price / Book: | 0.41 |
Profitability
| EPS (TTM): | -8.51120 |
|---|---|
| Net Income (TTM): | $-40M |
| Gross Margin: | $-84K |
| Return on Equity: | -760.4% |
| Return on Assets: | -150.5% |
Windtree Therapeutics, Inc. Earnings Forecast
Key Windtree Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 30 years have been positive in 19 years.
Windtree Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | WINT |
| CUSIP: | 97382D |
| Website: | windtreetx.com |
Debt
| Debt-to-Equity Ratio: | -1.11 |
|---|---|
| Current Ratio: | 0.33 |
| Quick Ratio: | 0.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
WINT Technical Analysis vs Fundamental Analysis
Sell
30
Windtree Therapeutics, Inc. (WINT)
is a Sell
Is Windtree Therapeutics, Inc. a Buy or a Sell?
-
Windtree Therapeutics, Inc. stock is rated a SellThe current Windtree Therapeutics, Inc. [WINT] share price is $0.06. The Score for WINT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.